Article

Updated: FDA Temporarily Removes List Of Hospitals, Providers That Received Products From Mass. Compounder

Just hours after posting it Monday, the Food and Drug Administration removed from its website a list of hospitals and doctors that had received products from the compounding pharmacy now at the center of the fungal meningitis outbreak, saying data may be incorrect.

The agency said it is working to correct the list and will repost once it is completed. Data had been supplied to the agency by the pharmacy, the New England Compounding Center in Massachusetts.

Read the full story: http://bit.ly/Rh58e8

Source: Kaiser Health News

Related Videos
Screenshot of an interview with Adam Colborn, JD
Justin Oldham, MD, MS, an expert on IPF
Justin Oldham, MD, MS, an expert on IPF
Screenshot of Stephanie Hsia, PharmD
Screenshot of an interview with James Chambers, PhD
Screenshot of an interview with Megan Ehret, PharmD
Interview screenshot with Megan Ehret, PharmD
Screenshot of an interview with Susan Wescott, RPh, MBA
Cesar Davila-Chapa, MD
1 KOL is featured in this series.
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo